Wordt geladen...
Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy
Immune checkpoint blockade (ICB) therapies have revolutionized the treatment of human cancers including lung adenocarcinoma (LUAD). However, our understanding of the immune subtyping of LUAD and its association with clinical response of immune checkpoint inhibitor remains incomplete. Here we perform...
Bewaard in:
| Gepubliceerd in: | Aging (Albany NY) |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Impact Journals
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7066911/ https://ncbi.nlm.nih.gov/pubmed/32091408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.102814 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|